The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones

被引:186
|
作者
Meek, Claire L. [1 ,2 ]
Lewis, Hannah B. [1 ]
Reimann, Frank [1 ]
Gribble, Fiona M. [1 ]
Park, Adrian J. [1 ,2 ]
机构
[1] Univ Cambridge, Addenbrookess Hosp, Inst Metab Sci, Metab Res Labs, Box 289,Hills Rd, Cambridge CB2 0QQ, England
[2] Addenbrookes Hosp, Dept Clin Biochem, Hills Rd, Cambridge CB2 0QQ, England
基金
英国惠康基金;
关键词
Bariatric; Ghrelin; Gastrin; Cholecystokinin; Incretin; Oxyntomodulin; GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; BETA-CELL FUNCTION; LAPAROSCOPIC SLEEVE GASTRECTOMY; DUODENAL-JEJUNAL EXCLUSION; PLASMA GHRELIN LEVELS; INDUCED WEIGHT-LOSS; BODY-WEIGHT; ILEAL TRANSPOSITION; GLUCOSE-METABOLISM;
D O I
10.1016/j.peptides.2015.08.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bariatric surgery for obesity has proved to be an extremely effective method of promoting long-term weight reduction with additional beneficial metabolic effects, such as improved glucose tolerance and remission of type 2 diabetes. A range of bariatric procedures are in common use, including gastric banding, sleeve gastrectomy and the Roux-en-Y gastric bypass. Although the mechanisms underlying the efficacy of bariatric surgery are unclear, gastrointestinal and pancreatic peptides are thought to play an important role. The aim of this review is to summarise the effects of different bariatric surgery procedures upon gastrointestinal and pancreatic peptides, including ghrelin, gastrin, cholecystokinin (CCK), glucose-dependent insulinotropic hormone (GIP), glucagon-like peptide 1 (GLP-1), peptide YY (PYY), oxyntomodulin, insulin, glucagon and somatostatin. (C) 2015 The Authors. Published by Elsevier Inc.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 50 条
  • [11] On premises and principles for measurement of gastrointestinal peptide hormones
    Albrechtsen, Nicolai J. Wewer
    Rehfeld, Jens F.
    PEPTIDES, 2021, 141
  • [12] Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery
    Chen, Xi
    Zhan, Jingjing
    Zhou, Zhiguang
    OBESITY SURGERY, 2019, 29 (09) : 3001 - 3009
  • [13] Secretion and Function of Gastrointestinal Hormones after Bariatric Surgery: Their Role in Type 2 Diabetes
    Shukla, Alpana
    Rubino, Francesco
    CANADIAN JOURNAL OF DIABETES, 2011, 35 (02) : 115 - 122
  • [14] Rat Models for Bariatric Surgery and Surgery for Type 2 Diabetes Mellitus
    Mistry, Sheetal Bharat
    Omana, Juan J.
    Kini, Subhash
    OBESITY SURGERY, 2009, 19 (05) : 655 - 660
  • [15] Metabolic surgery and gut hormones - A review of bariatric entero-humoral modulation
    Ashrafian, Hutan
    le Roux, Carel W.
    PHYSIOLOGY & BEHAVIOR, 2009, 97 (05) : 620 - 631
  • [16] Management of gastrointestinal bleeding following bariatric surgery
    Giannopoulos, Spyridon
    Pokala, Bhavani
    Stefanidis, Dimitrios
    MINI-INVASIVE SURGERY, 2022, 6
  • [17] Obesity, Gut Hormones, and Bariatric Surgery
    Dimitrios J. Pournaras
    Carel W. le Roux
    World Journal of Surgery, 2009, 33 : 1983 - 1988
  • [18] Changes in neurohormonal gut peptides following bariatric surgery
    Ochner, C. N.
    Gibson, C.
    Shanik, M.
    Goel, V.
    Geliebter, A.
    INTERNATIONAL JOURNAL OF OBESITY, 2011, 35 (02) : 153 - 166
  • [19] Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review
    Tabasi, Mohsen
    Ashrafian, Fatemeh
    Khezerloo, Jamil Kheirvari
    Eshghjoo, Sahar
    Behrouzi, Ava
    Javadinia, Seyed Alireza
    Poursadegh, Farid
    Eybpoosh, Sana
    Ahmadi, Sara
    Radmanesh, Amin
    Soroush, Ahmadreza
    Siadat, Seyed Davar
    OBESITY SURGERY, 2019, 29 (05) : 1663 - 1674
  • [20] Effect of Bariatric Surgery on Hypertension: A Meta-analysis
    Wilhelm, Sheila M.
    Young, Jamie
    Kale-Pradhan, Pramodini B.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) : 674 - 682